Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Calhoun

Showing results (31-40 of 188) with videos related to

Pageof 19
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2011
Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diureticsMurray Epstein, David A Calhoun
Journal of Hypertension|December 14, 2011
Hypertension and orthostatic hypotension in older patientsEric Judd, David A Calhoun
Cardiology Clinics|July 13, 2010
The role of aldosteronism in causing obesity-related cardiovascular riskDavid A Calhoun, Kumar Sharma
American Journal of Hypertension|November 14, 2016
Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension TreatmentTanja Dudenbostel, David A Calhoun
Journal of Hypertension|September 14, 2004
Weight gain and hypertension: the chicken-egg question revisitedDavid A Calhoun, Guido Grassi
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Aldosterone, dietary salt, and renal diseaseEduardo Pimenta, David A Calhoun
Current Hypertension Reports|March 21, 2018
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic SyndromeBadhma Valaiyapathi, David A Calhoun
Advances in Chronic Kidney Disease|February 24, 2015
Management of hypertension in CKD: beyond the guidelinesEric Judd, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step Beyond Observed RiskEric Judd, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
Resistant Hypertension: An Update of Experimental and Clinical FindingsAnping Cai, David A Calhoun
Pageof 19

Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2011
Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diureticsMurray Epstein, David A Calhoun
Journal of Hypertension|December 14, 2011
Hypertension and orthostatic hypotension in older patientsEric Judd, David A Calhoun
Cardiology Clinics|July 13, 2010
The role of aldosteronism in causing obesity-related cardiovascular riskDavid A Calhoun, Kumar Sharma
American Journal of Hypertension|November 14, 2016
Effects of Spironolactone and Renal Denervation Treatment on Blood Pressure and Its Variability-Different Aspects of Hypertension TreatmentTanja Dudenbostel, David A Calhoun
Journal of Hypertension|September 14, 2004
Weight gain and hypertension: the chicken-egg question revisitedDavid A Calhoun, Guido Grassi
Hypertension (Dallas, Tex. : 1979)|June 28, 2006
Aldosterone, dietary salt, and renal diseaseEduardo Pimenta, David A Calhoun
Current Hypertension Reports|March 21, 2018
Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic SyndromeBadhma Valaiyapathi, David A Calhoun
Advances in Chronic Kidney Disease|February 24, 2015
Management of hypertension in CKD: beyond the guidelinesEric Judd, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step Beyond Observed RiskEric Judd, David A Calhoun
Hypertension (Dallas, Tex. : 1979)|May 17, 2017
Resistant Hypertension: An Update of Experimental and Clinical FindingsAnping Cai, David A Calhoun
Pageof 19